Caffeine and Progression of Parkinson Disease.
Simon, DK, CJ Swearingen, RA Hauser, JM Trugman, MJ Aminoff, C Singer, D Truong, and BC Tilley. 2008. “Caffeine and Progression of Parkinson Disease.”. Clin Neuropharmacol.
Search
Search results
376 results found
Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations.
Hauser, RA, LM Shulman, JM Trugman, JW Roberts, A Mori, R Ballerini, and NM Sussman. 2008. “Study of Istradefylline in Patients With Parkinson’s Disease on Levodopa With Motor Fluctuations.”. Mov Disord.
Medical treatment of motor and nonmotor features of Parkinson’s disease.
Zesiewicz, TA, and RA Hauser. 2007. “Medical Treatment of Motor and Nonmotor Features of Parkinson’s Disease.”. Continuum.
Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson’s disease.
Hauser, RA, L Salin, N Juhel, and VL Konyago. 2007. “Randomized Trial of the Triple Monoamine Reuptake Inhibitor NS 2330 (tesofensine) in Early Parkinson’s Disease.”. Movement Disorders.
Treatment of chorea with levetiracetam.
Zesiewicz, TA, A Pathak, KL Sullivan, M Shamayev, and RA Hauser. 2006. “Treatment of Chorea With Levetiracetam.”. Eur J Clin Pharmacol.
Topiramate-induced psychosis in patients with essential tremor: report of 2 cases.
Ziesiewicz, TA, A Tullidge, J Tidwell, KL Sullivan, and RA Hauser. 2006. “Topiramate-Induced Psychosis in Patients With Essential Tremor: Report of 2 Cases.”. Clinical Neuropharmacology.
Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention: a joint statement from the American Academy of Neurology...
Connors, JJ, D Sacks, AJ Furlan, WR Selman, EJ Russell, PE Stieg, MN Hadley, RA Hauser, and . 2005. “Training, Competency, and Credentialing Standards for Diagnostic Cervicocerebral Angiography, Carotid Stenting, and Cerebrovascular Intervention: A Joint Statement from the American Academy of Neurology. ”. Neurology.
Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology.
Zesiewicz, TA, R Elble, ED Louis, RA Hauser, KL Sullivan, RB Dewey, and . 2005. “Quality Standards Subcommittee of the American Academy of Neurology. Practice Parameter: Therapies for Essential Tremor: Report of the Quality Standards Subcommittee of the American Academy of Neurology.”. Neurology.
Positron emission tomography after fetal transplantation in Huntington’s disease. Ann Neurol 2005; 58:331-337.
Furtado, S, V Sossi, RA Hauser, A Samii, M Schulzer, CB Murphy, TB Freeman, and AJ Stoessl. 2005. “Positron Emission Tomography After Fetal Transplantation in Huntington’s Disease. Ann Neurol 2005; 58:331-337.”. Ann Neurol.
Chorea in a patient with cerebral palsy: treatment with levetiracetam. Movement Disorders 2005;20:762-764.
Recio, MV, RA Hauser, ED Louis, H Radhashakar, KL Sullivan, and TA Zesiewicz. 2005. “Chorea in a Patient With Cerebral Palsy: Treatment With Levetiracetam. Movement Disorders 2005;20:762-764.”. Movement Disorders.